Company Overview of Sofinnova Ventures, Inc.
Sofinnova Ventures, Inc. is a venture capital firm specializing in seed, startup, early stage, series A, first venture round, and corporate spinouts. It also considers investments in intermediate and later stage startup companies. The firm does not invest in healthcare services, tool-kit companies, diagnostics, and neutraceuticals. It seeks to invest in life sciences and information technology sectors. In life sciences sector, it seeks to invest in clinical stage pharmaceutical products companies, biotechnology, therapeutic drug or product companies in the late preclinical or Phase I clinical stage, drug companies to treat diseases with unmet medical needs, drug discovery platform technology...
140 Geary Street
San Francisco, CA 94108
Founded in 1974
Key Executives for Sofinnova Ventures, Inc.
Founder and Managing Partner
Chief Financial Officer and Partner
General Partner, Managing Partner, and Partner
Compensation as of Fiscal Year 2014.
Sofinnova Ventures, Inc. Key Developments
aTyr May Go For IPO
Apr 1 15
A big venture round led by Sofinnova Ventures, Inc. and backed by a lengthy string of biotech stalwarts and public investment firms is bound to get tongues wagging again about a possible IPO in the near future for aTyr Pharma Inc.
Sofinnova Ventures, Inc. Presents at Biocom's Global Life Science Partnering Conference, Feb-25-2015 03:30 PM
Jan 28 15
Sofinnova Ventures, Inc. Presents at Biocom's Global Life Science Partnering Conference, Feb-25-2015 03:30 PM. Venue: The Lodge at Torrey Pines, 11480 North Torrey Pines Road, La Jolla, CA 92037, United States. Speakers: David S. Kabakoff, Executive Partner and Partner at Sofinnova Venture Partners VIII.
Sofinnova Ventures Appoints Daniel G. Welch to Executive Partner
Jan 8 15
Sofinnova Ventures announced that Daniel G. Welch, former CEO of InterMune, has joined the Sofinnova team as an Executive Partner. Welch has a distinguished track record as a biotech executive, with over 30 years of experience across both multi-national pharmaceutical companies and biotech companies. Most recently, he was the Chairman, CEO and President of InterMune.
Similar Private Companies By Industry
Recent Private Companies Transactions